A 50-year-old male visited the outpatient clinic and complained of fever, poor oral intake, and weight loss. A chest X-ray demonstrated streaky and fibrotic lesions in both lungs, and chest CT revealed multifocal peribronchial patchy ground-glass opacities with septated cystic lesions in both lungs. Cell counts in the bronchoalveolar lavage fluid revealed lymphocyte-dominant leukocytosis, and further analysis of lymphocyte subsets showed a predominance of cytotoxic T cells and few T helper cells. Video-assisted wedge resection of the left upper lobe was performed, and the histologic examination was indicative of a Pneumocystis jirovecii infection. Trimethoprim-sulfamethoxazole (TMP-SMX) was orally administered for 3 weeks; however, the patient complained of cough, and the pneumonia was aggravated in the follow-up chest X-ray and chest CT. Molecular studies demonstrated mutations at codons 55 and 57 of the dihydropteroate synthase (DHPS) gene, which is associated with the resistance to TMP-SMX. Clindamycin-primaquine was subsequently administered for 3 weeks replacing the TMP-SMX. A follow-up chest X-ray showed that the pneumonia was resolving, and the cough was also alleviated. A positive result of HIV immunoassay and elevated titer of HCV RNA indicated HIV infection as an underlying condition. This case highlights the importance of careful monitoring of patients with P. jirovecii pneumonia (PCP) during the course of treatment, and the molecular study of DHPS mutations. Additionally, altering the anti-PCP drug utilized as treatment must be considered when infection with drug-resistant P. jirovecii is suspected. To the best of our knowledge, this is the first case of TMP-SMX-resistant PCP described in Korea.
Citations
Citations to this article as recorded by
Molecular Study of Pneumocystis jirovecii in Respiratory Samples of HIV Patients in Chile Isabel Iturrieta-González, Carolina Chahin, Johanna Cabrera, Carla Concha, Pamela Olivares-Ferretti, Javier Briones, Fernando Vega, Luis Bustos-Medina, Flery Fonseca-Salamanca Journal of Fungi.2024; 10(2): 117. CrossRef
Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate Francois D. Rouleau, Alexandre K. Dubé, Isabelle Gagnon-Arsenault, Soham Dibyachintan, Alicia Pageau, Philippe C. Després, Patrick Lagüe, Christian R. Landry, Adrian Serohijos PLOS Genetics.2024; 20(4): e1011252. CrossRef
Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T. Zangeneh, Ahmad Iftikhar Avicenna Journal of Medicine.2023; 13(01): 023. CrossRef
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications Thomas R Rogers, Paul E Verweij, Mariana Castanheira, Eric Dannaoui, P Lewis White, Maiken Cavling Arendrup, M C Arendrup, S Arikan-Akdagli, F Barchiesi, Jochem Buil, M Castanheira, E Chryssanthou, N Friberg, J Guinea, P Hamal, Ingibjorg Hilmarsdottir, N Journal of Antimicrobial Chemotherapy.2022; 77(8): 2053. CrossRef
Effectiveness of front line and emerging fungal disease prevention and control interventions and opportunities to address appropriate eco-sustainable solutions Mary Garvey, Elaine Meade, Neil J. Rowan Science of The Total Environment.2022; 851: 158284. CrossRef
Chloroquine Analogues as Leads against Pneumocystis Lung Pathogens Ana Gomes, Ricardo Ferraz, Lauren Ficker, Margaret S. Collins, Cristina Prudêncio, Melanie T. Cushion, Cátia Teixeira, Paula Gomes Antimicrobial Agents and Chemotherapy.2018;[Epub] CrossRef
Therapy and Management of Pneumocystis jirovecii Infection P. Lewis White, Jessica S. Price, Matthijs Backx Journal of Fungi.2018; 4(4): 127. CrossRef
Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort Isabelle Suárez, Lisa Roderus, Edeltraud van Gumpel, Norma Jung, Clara Lehmann, Gerd Fätkenheuer, Pia Hartmann, Georg Plum, Jan Rybniker Infection.2017; 45(3): 341. CrossRef
La pneumocystose au cours de l’infection à VIH M. El Fane, M. Sodqi, A. Oulad Lahsen, A. Chakib, L. Marih, K. Marhoum El Filali Revue de Pneumologie Clinique.2016; 72(4): 248. CrossRef
Managing the oncologic patient with suspected pneumonia in the intensive care unit D. Leoni, B. Encina, J. Rello Expert Review of Anti-infective Therapy.2016; 14(10): 943. CrossRef
A Case of Pneumonia Caused byPneumocystis jiroveciiResistant to Trimethoprim/Sulfamethoxazole in the Absence of Previous Drug Exposure Ari Ahn, Jeonghyun Chang, Heungsup Sung, Mi-Na Kim Laboratory Medicine Online.2016; 6(4): 250. CrossRef
First
Prev
